MGNX MacroGenics, Inc.
$4.00▲ +0.76%
Healthcare
Other
After hours
$4.00▲ +0.00%
Sep 11, 7:30 PM ET
Volume 381.9K
Avg Volume (10D) 486.1K
Key Metrics & Fundamentals
Market Cap
$254.80M
P/E Ratio
–
Div Yield
–%
52W Range
1.29 - 5.08
% vs 50 MA
-3.61%
% vs 200 MA
30.04%
RSI-14
46.1
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.04
Free Cash Flow
-$41.55M
Gross Rev
$32.83M
Gross Profit
$32.83M
EBITDA
-$11.78M
COGS
–
Operating Exp
$46.68M
Operating Income
-$13.85M
EBIT
-$13.85M
Pretax Income
-$69.64M
Net Income
$19.52M
EPS (Diluted)
0.31
Price & Volume History
Loading chart…
Recent News
MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 9, 2026 8:05 PM
Is MacroGenics (MGNX) Stock Outpacing Its Medical Peers This Year?
Zacks · Aug 20, 2026 1:40 PM
B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating
MT Newswires · Aug 17, 2026 11:49 AM
Can MacroGenics (MGNX) Turn Gilead Sciences (GILD)’s $10M Milestone Into a Major Pipeline Catalyst?
Insider Monkey · Aug 15, 2026 12:50 AM
MacroGenics (MGNX) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 13, 2026 10:50 PM
MacroGenics: Q2 Earnings Snapshot
Associated Press · Aug 13, 2026 9:05 PM
MacroGenics Reports Second Quarter 2026 Financial Results, Streamlined Operating Model and Strengthened Financial Position
GlobeNewswire · Aug 13, 2026 8:05 PM
Sanara MedTech Inc. (SMTI) Tops Q2 Earnings Estimates
Zacks · Aug 11, 2026 11:10 PM
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
GlobeNewswire · Aug 11, 2026 8:05 PM
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates
Zacks · Aug 6, 2026 9:40 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See MGNX's money flow as a full page
Social Sentiment
No Reddit posts found for MGNX.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.